Gemneo Bioscience

Gemneo Bioscience, the 100th company to spin out from the ideas of ASU faculty and staff, will provide physicians with more optimal cancer treatments and groundbreaking immunotherapies to help improve cancer outcomes.

Joseph Blattman, a researcher at ASU’s Biodesign Institute, is leading a spinout venture, called Gemneo Biosciences. After arriving at ASU, Blattman worked with Professor Hao Yan to create a new immune cell profiling technology that identifies each patient’s unique tumor signature. The technology also identifies rogue cells that current technologies have not been able to detect. Additionally, it suggests key immune elements to exploit during immunotherapy.

“With cancer, the more diverse the cancer cells, the more difficult it is to identify the most effective treatment,” Blattman said. “Our technology will give physicians a more precise tool for more effectively treating cancer – and a host of other diseases.”

“Our technology overcomes a major limitation of current deep-sequencing approaches, which struggle to identify particular combinations of immune receptors or cancer mutations,” Blattman said. “ Gemneo allows us to interrogate individual cells to identify T-cell receptors and antibody sequences for diagnostics or therapeutic approaches, as well as rare combinations of cancer mutations occurring at the single cell level. In the future, this will facilitate personalized therapeutic approaches and better outcomes for cancer treatment.”

Anil Shrikhande, Gemneo’s CEO, founded the company while participating as an executive-in-residence with the ASU Startup Mill, which matches high-potential startups with seasoned venture capitalists and executives. Shrikhande previously led Rolls-Royce South Asia and Boeing India, as well as new venture development for Boeing Ventures.

“The Gemneo team is honored to be the 100th spinout company formed based on ASU’s extensive wide-ranging research efforts,” Shrikhande said. “This milestone is a testament to ASU’s longstanding commitment to excellence in research coupled with the unique innovation and entrepreneurial ecosystem that ASU has established to seed and nurture the creation of faculty and student ventures.”

To learn more information about Gemneo, please use the contact form below.